Elevance Health (ELV) Q4 2024 Earnings Call Transcript
Operator instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to the company's management. Please go ahead.Nathan Rich -- Vice President, Investor Relations Good morning,
Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress
Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for significant upside.
Elevance Health reports Q4 adjusted EPS $3.84, consensus $3.86
Reports Q4 revenue $45B, consensus $44.72B. “As part of our commitment to elevating whole health and advancing health beyond healthcare, we
Elevance Health expects to grow MA membership by at least 7% in 2025
Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's expectations despite decreasing 51% year-over-year. | Elevance Health posted $418 million in profit for the fourth quarter of 2024,
Elevance Health Q4 earnings miss estimates, stock rises
The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue came in at $45 billion, slightly above the $44.9 billion analysts had projected and up 6% year-over-year.
Elevance Health Q4 Countdown: Smart Move to Buy or Stick With Hold?
ELV's fourth-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.
Elevance Health: Q4 Earnings Snapshot
For the year, the company reported profit of $5.98 billion, or $25.68 per share. Revenue was reported as $175.2 billion. Elevance Health expects full-year earnings in the range of $34.15 to $34.85 per share.
Elevance Health Q4 Ad. EPS Miss Market, Revenues Beat; Sees Growth In FY25, Lifts Dividend; Stock Up
Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025
Elevance Earnings: Stock Rises After Results, Guidance Match Expectations
Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results marked t
Elevance Health Beats Fourth-Quarter Estimates, Sees Annual Growth in 2025
Elevance Health (ELV) reported better-than-expected fourth-quarter results on Thursday, while the health insurer anticipates its 2025 earnings and revenue to rise year over year. The company anticipates adjusted earnings to be in a range of $34.
Elevance sends Medicaid insurers higher after Q4 revenue beat
Centene (CNC) and Molina Healthcare (MOH) were among the notable gainers in the premarket on Thursday after their rival in the Medicaid space, Elevance Health (NYSE:ELV), reported better-than-expected revenue for Q4 2024.
Hosted on MSN17h
Elevance Health Stock Rises On Upbeat Q4 Revenue, Dividend Boost: Retail's Over The Moon
Shares of Elevance Health Inc. climbed over 2.5% on Thursday morning, hitting levels last seen in early December. The rise came as the health insurer reported better-than-expected fourth-quarter ...
Elevance Health Posts Q4 Profit Despite Medicaid Drop, Rising Costs; Hikes Dividend 5%
Elevance Health Q4 revenues hit $45 billion, driven by premium growth and acquisitions. 2025 EPS guidance is $34.15-$34.85, with a $1.71 dividend declared.
Yahoo Finance6d
Unveiling Elevance Health (ELV) Q4 Outlook: Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Elevance Health (ELV) will report quarterly earnings of $3.82 per share in its upcoming release, pointing to a year-over-year decline of 32%. It is anticipated ...